Maher Albitar, Chief Medical Officer at NEOGENOMICS INC (NEO), sold 210,600 shares at $8.20 ($1.7M) on 2016-09-20, disclosed to the SEC on 2016-09-22.
Open-market sale of $1.7M NEO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.20 | 105,300 | $863K | 50.0% |
| 2 | $8.20 | 105,300 | $863K | 50.0% |
| Total | $8.20 avg | 210,600 | $1.7M | 100% |
| Filing → |
| NEO | SELL | 2016-08-23 | $3.0M | — | Filing → |
| NEO | BUY | 2014-03-31 | $51K | — | Filing → |